Cauliflower

OTHER NAME(S): Blumenkohl, Cavolfiore, Cavolo Broccoli, Cavolfiore, Cavolo Fiore, Chou Broccoli, Chou Fleur, Chou Fleur D'hiver, Common Cauliflower, Couve Flor, Hana Kyabetsu, Hana Yasai, Hua Ye Cai, Kalafior, Kapusta Tsvetnaia, Karifurawaa, Kopfbrokkoli, Lillkapsas, Phuul Gobhii, Brassica oleracea, Coliflor, Chou-fleur

Overview

Cauliflower is a vegetable. The head or curd of cauliflower is commonly eaten as food. It is also used as medicine.

Cauliflower is used for obesity, heart disease, diabetes, cancer, and other conditions, but there is no good scientific evidence to support these uses.

Cauliflower contains chemicals that might help the body get rid of components from food or the environment that are thought to cause cancer. Cauliflower might also have antioxidant activity.

Cauliflower contains chemicals that might help the body get rid of components from food or the environment that are thought to cause cancer. Cauliflower might also have antioxidant activity.

References
  1. Stoewsand GS. Bioactive organosulfur phytochemicals in Brassica oleracea vegetables--a review. Food Chem Toxicol 1995;33:537-43.
  2. van Poppel G, Verhoeven DT, Verhagen H, Goldbohm RA. Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 1999;472:159-68.
  3. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999;282:1233-39.
  4. Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer 2002;42:1-9.
  5. Finley JW. The antioxidant responsive element (ARE) may explain the protective effects of cruciferous vegetables on cancer. Nutr Rev 2003;61:250-4.
  6. Zhao H, Lin J, Grossman HB, et al. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 2007;120:2208-13.
  7. Cohen, J. H., Kristal, A. R., and Stanford, J. L. Fruit and vegetable intakes and prostate cancer risk. J Natl.Cancer Inst. 1-5-2000;92(1):61-68.
  8. Michaud DS, Spiegelman D, Clinton SK, et al. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 1999;91(7):605-13.
  9. Feskanich D, Ziegler RG, Michaud DS, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000;92(22):1812-23.
  10. Chang ET, Smedby KE, Zhang SM, et al. Dietary factors and risk of non-Hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev 2005;14(2):512-20.
  11. Liu S, Serdula M, Janket SJ, et al. A prospective study of fruit and vegetable intake and the risk of type 2 diabetes in women. Diabetes Care 2004;27(12):2993-6.
  12. Gaudet MM, Britton JA, Kabat GC, et al. Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev 2004;13(9):1485-94.
  13. Peterson S, Schwarz Y, Li SS, et al. CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial. Cancer Epidemiol Biomarkers Prev 2009;18(11):3118-25.
  14. Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Lett 2006;233(2):208-218.
  15. Hanf V, Gonder U. Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk. Eur J Obstet Gynecol Reprod Biol 2005;123(2):139-149.
  16. Osborne MP. Chemoprevention of breast cancer. Surg Clin North Am 1999;79(5):1207-1221.
  17. Ferguson LR. Micronutrients, dietary questionnaires and cancer. Biomed Pharmacother 1997;51(8):337-344.
  18. Verhoeven DT, Verhagen H, Goldbohm RA, van den Brandt PA, van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 1997;103(2):79-129.
  19. Fowke JH, Morrow JD, Motley S, Bostick RM, Ness RM. Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake. Carcinogenesis 2006;27(10):2096-2102.
  20. Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 2006;6(2):135-145.
  21. Morel F, Langouet S, Maheo K, Guillouzo A. The use of primary hepatocyte cultures for the evaluation of chemoprotective agents. Cell Biol Toxicol 1997;13(4-5):323-329.
  22. Bradfield CA, Bjeldanes LF. Modification of carcinogen metabolism by indolylic autolysis products of Brassica oleraceae. Adv Exp Med Biol 1991;289:153-163.
  23. Thomson CA, Rock CL, Caan BJ, et al. Increase in cruciferous vegetable intake in women previously treated for breast cancer participating in a dietary intervention trial. Nutr Cancer 2007;57(1):11-19.
  24. Wagner AE, Huebbe P, Konishi T, et al. Free radical scavenging and antioxidant activity of ascorbigen versus ascorbic acid: studies in vitro and in cultured human keratinocytes. J Agric Food Chem 2008;56(24):11694-11699.
  25. Wattenberg, L. W. Effects of dietary constituents on the metabolism of chemical carcinogens. Cancer Res 1975;35(11 Pt. 2):3326-3331.
  26. Firestone, G. L. and Bjeldanes, L. F. Indole-3-carbinol and 3-3'-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 2003;133(7 Suppl):2448S-2455S.
  27. Dalessandri, K. M., Firestone, G. L., Fitch, M. D., Bradlow, H. L., and Bjeldanes, L. F. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 2004;50(2):161-167.
  28. Crowell, J. A., Page, J. G., Levine, B. S., Tomlinson, M. J., and Hebert, C. D. Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450. Toxicol.Appl.Pharmacol. 3-1-2006;211(2):115-123.
  29. Aggarwal, B. B. and Ichikawa, H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005;4(9):1201-1215.
  30. Higdon, J. V., Delage, B., Williams, D. E., and Dashwood, R. H. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 2007;55(3):224-236.
  31. Steinkellner, H., Rabot, S., Freywald, C., Nobis, E., Scharf, G., Chabicovsky, M., Knasmuller, S., and Kassie, F. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 2001;480-481:285-297.
  32. Conaway, C. C., Yang, Y. M., and Chung, F. L. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002;3(3):233-255.
  33. Blomhoff, R. Dietary antioxidants and cardiovascular disease. Curr Opin Lipidol 2005;16(1):47-54.
  34. Shannon MC, Grieve CM. Tolerance of vegetable crops to salinity. Scientia Horticulturae 1999;78:5-38.
  35. Singh G, Kawatra A, Sehgal S. Nutritional composition of selected green leafy vegetables, herbs and carrots. Plant Foods Hum Nutr 2001;56(4):359-64.
  36. Smyth DR. Flower development. Origin of the cauliflower. Curr Biol 1995;5(4):361-3.
  37. Branca F. "Cauliflower and Broccoli. Vegetables I. New York: Springer, 2008;151-186.
  38. Kellingray L, Tapp HS, Saha S, Doleman JF, Narbad A, Mithen RF. Consumption of a diet rich in Brassica vegetables is associated with a reduced abundance of sulphate-reducing bacteria: A randomised crossover study. Mol Nutr Food Res 2017;61(9). doi: 10.1002/mnfr.201600992.
  39. Vanduchova A, Tomankova V, Anzenbacher P, Anzenbacherova E. Influence of sulforaphane metabolites on activities of human drug-metabolizing cytochrome P450 and determination of sulforaphane in human liver cells. J Med Food 2016;19(12):1141-6.